{"id":"NCT01129882","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia","officialTitle":"An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Patients With Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06-24","primaryCompletion":"2018-12-06","completion":"2018-12-06","firstPosted":"2010-05-25","resultsPosted":"2020-01-06","lastUpdate":"2020-01-06"},"enrollment":709,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":[]}],"arms":[{"label":"Aripiprazole IM depot","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study was to continue to provide aripiprazole intramuscular (IM) depot treatment (400 milligrams \\[mg\\] or 300 mg) to participants with schizophrenia completing the 52-week, open-label safety and tolerability Study 31-08-248. In addition, the secondary objective was to collect additional long-term safety data on aripiprazole IM depot treatment.","primaryOutcome":{"measure":"Number Of Participants Reporting Severe Treatment-Emergent Adverse Events (TEAE)","timeFrame":"Baseline to Month 97 (+/- 3 days)","effectByArm":[{"arm":"Aripiprazole IM Depot","deltaMin":50,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":10},"locations":{"siteCount":157,"countries":["United States","Argentina","Australia","Bulgaria","Chile","Croatia","Estonia","Finland","Hungary","India","Malaysia","Mexico","Philippines","Poland","Puerto Rico","Romania","Russia","Serbia","Slovakia","South Africa","South Korea","Spain","Taiwan","Thailand"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":62,"n":709},"commonTop":["Nasopharyngitis","Weight Increased","Headache","Insomnia","Upper Respiratory Tract Infection"]}}